Hologic, Inc. (HOLX) Shareholder/Analyst Call - Slideshow

Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics

The headline numbers for Hologic (HOLX) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Hologic $8.75 Billion Buyout Loan to Wrap Up With Strong Demand

The $8.75 billion debt financing tied to the buyout of medical-device maker Hologic Inc. has been widely considered the leveraged loan market’s first big test of the year. Ahead of its expected pricing on Wednesday, it sent a clear signal that demand for risky debt is strong.

Hologics GYN Surgical Segment Looks Poised for Long-Term Growth

HOLXs GYN Surgical unit gains momentum as the demand for gynecological devices rises globally, driven by innovation, M&A and strong overseas adoption.

VNRX: 3Q 2025 results reported; Revenues & EPS above our expectations; cost cutting very evident. At least seven major operational milestones have been achieved thus far in 2025.

By Steven Ralston, CFANYSE:VNRXREAD THE FULL VNRX RESEARCH REPORTEXECUTIVE SUMMARYVolitionRx’s (NYSE:VNRX): Management’s primary operational goal for 2025 is to secure multiple licensing agreements for human diagnostic applications. In September 2025, Volition began significant progress toward the goal by signing two licensing agreements: a Nu.Q NETs Research License with Werfen S.A. for Antiphospholipid Syndrome (APS) and a co-marketing agreement with Hologic Diagenode for Nu.Q Discover se...

Palmer Square BDC (PSBD) Earnings Transcript

Image source: The Motley Fool.DATEWednesday, Nov. 5, 2025 at 1 p.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Christopher LongPresident and Chief Investment Officer — Angie LongManaging Director and Head of Investments — Matthew BloomfieldChief Financial Officer — Jeffrey FoxManaging Director — Jeremy GoffNeed a quote from a Motley Fool analyst? Email [email protected] Deployment -- $138.7 million deployed during Q3 2025, indicating continued origination activity.T...

Key deals this week: United States Antimony, Grindr, Eli Lilly, Hologic and more

Wave of private equity deals continues with TPG and Blackstone’s Hologic takeover

Transaction comes as industry’s biggest buyout groups collectively seek to deploy more than $2tn in unused cash

Blackstone and TPG Agree to $18 Billion Deal to Buy Hologic

Blackstone Inc. and TPG Inc. have agreed to acquire medical-device maker Hologic Inc. for as much as $18.3 billion, including debt, adding to the flurry of multibillion-dollar dealmaking by private equity firms in recent weeks.

Blackstone, TPG Near Hologic Deal for More Than $17 Billion

Blackstone Inc. and TPG Inc. are in advanced negotiations to acquire Hologic Inc. in a deal that could value the medical device maker at more than $17 billion including debt, according to people familiar with the matter.

Hologic (HOLX) Stock Moves -1.25%: What You Should Know

The latest trading day saw Hologic (HOLX) settling at $67.76, representing a -1.25% change from its previous close.

Why Hologic (HOLX) Outpaced the Stock Market Today

In the closing of the recent trading day, Hologic (HOLX) stood at $67.91, denoting a +1.3% move from the preceding trading day.

Hologic - Gesundheitskonzern profitiert von steigenden Behandlungszahlen!

Geschäftstreiber: Hologic (HOLX) hat sich im Bereich Diagnostik und Medizinische Bildgebungsverfahren einen Namen gemacht und gilt auch bei fortschrittlicher Labor- und Medizintechnik als einer der führenden...

HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?

Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.

Hologic (HOLX) Laps the Stock Market: Heres Why

In the closing of the recent trading day, Hologic (HOLX) stood at $65.37, denoting a +2.64% move from the preceding trading day.

Why Hologic (HOLX) Dipped More Than Broader Market Today

The latest trading day saw Hologic (HOLX) settling at $63.26, representing a -2.1% change from its previous close.

Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing

In the latest trading session, Hologic (HOLX) closed at $65.85, marking a +1.46% move from the previous day.

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Hologic (HOLX) closed at $65.11, indicating a +1.31% shift from the previous trading day.

Hologics Margin Stability Amid Tariffs: Whats Behind the Confidence?

HOLX lifts margins despite tariffs and weak China sales, leaning on diagnostics strength and high-margin buys.

TPG and Blackstone offered $16bn to take health group Hologic private

US-listed company turned down approach from private equity giants

Hologic reportedly rejects $16B go-private offer from TPG, Blackstone

TPG and Blackstone Inc (NYSE:BX), two private equity firms, have made a non-binding offer of more than $16 billion to take medical equipment-maker Hologic...

HOLX vs. DGX: Which Womens Health-Focused Stock Is the Better Pick?

The womens health market is booming, with Hologic and Quest Diagnostics leading the charge. But which one stands out more for investors today?

Hologic (HOLX) Stock Moves -1.08%: What You Should Know

In the most recent trading session, Hologic (HOLX) closed at $56.94, indicating a -1.08% shift from the previous trading day.

Hologic (HOLX) Advances But Underperforms Market: Key Facts

In the most recent trading session, Hologic (HOLX) closed at $61.89, indicating a +0.68% shift from the previous trading day.

Investing in Hologic (NASDAQ:HOLX) five years ago would have delivered you a 76% gain

It hasnt been the best quarter for Hologic, Inc. ( NASDAQ:HOLX ) shareholders, since the share price has fallen 15% in...

HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?

As Hologic works through the changing macroeconomic and geopolitical landscape, its long-term potential makes it a solid hold.

Hologic (HOLX) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Hologic (HOLX) closed at $61.82, marking a +1.83% move from the previous day.

Lumos Diagnostics expands scope of work under Hologic fetal fibronectin development agreement

Lumos Diagnostics Holdings Ltd has inked an agreement with leading women’s health company, Hologic, Inc, to expand the scope of work under the development...

Hologic outlines Q2 revenue guidance of $995M–$1.005B amid expected diagnostics growth